oral cavity carcinoma
Showing 1 - 25 of >10,000
Alcohol-Related Carcinoma, Fanconi Anemia, Oral Cavity Carcinoma Trial in Minneapolis (Alcohol, Biospecimen Collection, Breath
Recruiting
- Alcohol-Related Carcinoma
- +2 more
- Alcohol
- +2 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Jul 25, 2023
Oral Cavity Squamous Cell Carcinoma Trial in San Francisco (NisinZ® P, Surgery (non-interventional, standard of care))
Not yet recruiting
- Oral Cavity Squamous Cell Carcinoma
- NisinZ® P
- Surgery (non-interventional, standard of care)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 18, 2023
Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IVA
Withdrawn
- Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity
- +6 more
- hypofractionated radiation therapy
- +3 more
-
New Brunswick, New Jersey
- +1 more
Sep 27, 2022
Head and Neck Carcinoma, Malignant Parotid Gland Tumor, Maxillary Sinus Carcinoma Trial in United States (Best Practice, Medical
Recruiting
- Head and Neck Carcinoma
- +6 more
- Best Practice
- Medical Device Usage and Evaluation
-
Phoenix, Arizona
- +3 more
Oct 10, 2022
Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8
Not yet recruiting
- Oral Cavity Squamous Cell Carcinoma
- +4 more
- Near Infrared Imaging
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 5, 2022
Oral Cavity Squamous Cell Carcinoma Trial in Yichang (Sintilimab, Radiotherapy)
Recruiting
- Oral Cavity Squamous Cell Carcinoma
- Sintilimab
- Radiotherapy
-
Yichang, Hubei, ChinaDepartment of Medical Oncology, Central Hospital of Yichang City
Feb 18, 2023
Oral Squamous Cell Carcinoma, Maxillo-facial Surgery, Biomarkers Trial in Amiens (saliva tube)
Recruiting
- Oral Squamous Cell Carcinoma
- +5 more
- saliva tube
-
Amiens, Picardie, FranceAmiens University Hospital
Mar 17, 2023
Erythroplakia, Leukoplakia, Oral Cavity Carcinoma Trial in Philadelphia (Metformin, Biopsy)
Recruiting
- Erythroplakia
- +3 more
- Metformin
- Biopsy
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Sep 7, 2022
Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous
Recruiting
- Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
- +50 more
- transoral robotic surgery
- quality of life assessment
-
Columbus, OhioOhio State University Medical Center
Oct 28, 2022
WORST PATTERN OF INVASION IN ORAL SQUAMOUS CELL CARCINOMA
Recruiting
- Oral Cancer
- +2 more
- Biopsy Specimens Histopathology
-
Rawalpindi, Punjab, PakistanArmed Forces Institute of Pathology
Jun 22, 2023
Squamous Cell Carcinoma of the Oral Cavity Trial in Rouen (Circulating tumor DNA detection)
Not yet recruiting
- Squamous Cell Carcinoma of the Oral Cavity
- Circulating tumor DNA detection
-
Rouen, France
- +1 more
Jun 29, 2023
Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Houston (drug, behavioral, radiation)
Not yet recruiting
- Squamous Cell Carcinoma
- Oral Cavity Squamous Cell Carcinoma
- Tiragolumab
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jan 27, 2023
Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy
Recruiting
- Squamous Cell Carcinoma of Oral Cavity
- +3 more
- Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
-
Gliwice, Silesia, PolandThe Maria Sklodowska-Curie National Research Institute of Oncolo
Aug 7, 2023
Oral Cavity Squamous Cell Carcinoma Trial in Leuven (Durvalumab, Durvalumab + Tremelimumab)
Active, not recruiting
- Oral Cavity Squamous Cell Carcinoma
- Durvalumab
- Durvalumab + Tremelimumab
-
Leuven, BelgiumUZ Leuven
May 30, 2022
Neoadjuvant Pembrolizumab in III-IVA Resectable Oral Squamous
Recruiting
- Oral Cavity Squamous Cell Carcinoma
-
Guangzhou, Guangdong, ChinaLiuxiqiang
Feb 1, 2023
Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication
Completed
- Caregiver
- +37 more
- Communication Intervention
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Dec 14, 2022
Stage I Oral Cavity Squamous Cell Carcinoma, Stage II Oral Cavity Squamous Cell Carcinoma Trial in Buffalo, Rochester (drug,
Terminated
- Stage I Oral Cavity Squamous Cell Carcinoma
- Stage II Oral Cavity Squamous Cell Carcinoma
- HPPH
- +4 more
-
Buffalo, New York
- +1 more
May 6, 2022
Head and Neck Carcinoma, Head and Neck Carcinoma of Unknown Primary, Hypopharyngeal Carcinoma Trial in Scottsdale, Rochester
Recruiting
- Head and Neck Carcinoma
- +10 more
- Cisplatin
- +3 more
-
Scottsdale, Arizona
- +1 more
Jan 6, 2023
Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Trial (Black Raspberry)
Not yet recruiting
- Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
- Black Raspberry
- (no location specified)
Oct 16, 2023
Articulatory Adaptation Following Oral Cancer Treatment
Recruiting
- Oral Cavity Squamous Cell Carcinoma
- Speech Disorders
- Electromagnetic Articulography
-
Groningen, Netherlands
- +1 more
May 25, 2023
Oral Cavity Squamous Cell Carcinoma Trial in Mumbai (Sentinel node biopsy)
Recruiting
- Oral Cavity Squamous Cell Carcinoma
- Sentinel node biopsy
-
Mumbai, Maharashtra, IndiaTata Memorial Hospital
Jul 15, 2023
Oropharyngeal Dysplasia, Oral Cavity Dysplasia, Oral Carcinoma in Situ Trial in Miami (APG-157)
Not yet recruiting
- Oropharyngeal Dysplasia
- +2 more
-
Miami, FloridaUniversity of Miami
May 9, 2023
Squamous Cell Carcinoma of Head and Neck Trial in Hangzhou (Toripalimab)
Recruiting
- Squamous Cell Carcinoma of Head and Neck
-
Hangzhou, Zhejiang, ChinaDepartment of Medical Onocology, First Affiliated Hospital of Zh
Oct 7, 2023
Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Jerusalem (Radiation: Diffusing Alpha Radiation Emitters
Not yet recruiting
- Squamous Cell Carcinoma
- Head and Neck Squamous Cell Carcinoma
- Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT
-
Jerusalem, IsraelSharett institute, Hadassah University Hospital - Ein-Kerem
Jul 4, 2022